
Doctor Michel Farnier
University of Bourgogne Franche Comte, Dijon (France)
Follow
Contributor content
Session
Dyslipidaemia management: a cornerstone in cardiovascular multimorbid patients’ care
1 September 2024
Session
Change of paradigm in dyslipidemia management
28 August 2022
Session
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition & cardiovascular outcomes: review of lipid targets and treatment strategies (EBAC Accredited)
26 August 2017

